Wednesday, August 20th, 2014

DUBLIN, IRELAND -- (Marketwired) -- Research and Markets (http://www.researchandmarkets.com/research/slmb9w/nuclear) has announced the addition of the "Nuclear Medicine/Radiopharmaceuticals Global market - Forecast to 2019" report to their offering.

The global nuclear medicine/radiopharmaceutical market is poised to reach around $6 billion by 2017 at a CAGR of more than 7%

The largest share in the global radiopharmaceuticals market is accounted by North America. Besides U.S. market Asia-Pacific region is also poised to show a remarkable growth. The Asia-Pacific radiopharmaceutical market is poised to reach approximately 14% by 2017 at a CAGR of around 11%. Countries such as China, India, Japan, South Korea, Brazil and South Africa possess reactors and other production units for isotopes. Moreover, the government initiative in funding the isotope manufacturers is also expected to boost the market growth.

The global nuclear medicine/radiopharmaceutical market is majorly comprised of five key players accounting for around 50% of the total market share. Key players include Covidien (), IBA Group, Lantheus Medical Imaging, Nordion, Triad Isotopes, Siemens Healthcare (PETNET Solutions), and NTP Radioisotopes. Acquisitions and mergers, new product launch, agreements and collaborations, and expansions were the main strategies followed by the key players in the global nuclear medicine market.

Key Topics Covered:

1.  Executive summary 
    
2.  Introduction 
    
3.  Market Analysis 
    
4.  Global Radiopharmaceutical market, by End-User 
    
5.  Global Radiopharmaceutical market, by Application 
    
6.  Stable Isotopes 
    
7.  Regional Market Analysis 
    
8.  Company Developments 
    
9.  Major Company Profiles 
    

--  CIL 
--  Cardinal Health, Inc. 
--  GE Healthcare 
--  IBA Group 
--  Isotec, Inc. (Sigma-Aldrich) 
--  Lantheus Medical Imaging, Inc. 
--  Mallinckrodt Plc 
--  NTP Radioisotopes 
--  Nordion Inc 
--  Taiyo Nippon Sanso Corporation 

For more information visit http://www.researchandmarkets.com/research/slmb9w/nuclear"> http://www.researchandmarkets.com/research/slmb9w/nuclear

Sector: Healthcare and Medical Devices

Over 400 of the Fortune 500 buy their research from Research and Markets. Some of our clients in the area of Healthcare and Medical Devices include:

--  Samsung Electronics Co., Ltd. 
--  McKinsey & Company, Inc. 
--  Siemens AG 
--  IGEN Biotech Group 
--  General Electric 
--  Medtronic Inc. 
--  Baxter International Inc. 
--  Merck & Co., Inc. 
--  Novartis International AG 
--  Philips N.V. 
--  Illumina, Inc. 
--  Nestle Health Science 
--  Brasseler USA 
--  Bio-Rad Laboratories 
--  Amgen, Inc. 
--  Smiths Medical 
Contacts:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Keywords

Research and Markets, market research, nuclear, medicine, radiopharmaceutical, marketing, report, forecast, health care

Categories

Sharing

More Formats